4processed

Form 4 — Insider Transaction

Maze Therapeutics, Inc.(MAZE)

Filing Date

May 29, 2026

Accepted

May 29, 2026

Accession No.

0002050167-26-000013

CIK

0001842295

Insider Transactions

InsiderTitleTypeSharesPriceValueOwned AfterSecurityDate
Dandekar AtulCSBOOther7.5K$10.4232.3KCommon StockMay 29, 2026
Dandekar AtulCSBOOther7.5K$26.34124.8KCommon StockMay 29, 2026
Dandekar AtulCSBOOther7.5K$036.6KStock Option (Right to Buy)May 29, 2026